Human Genome Sciences (HGSI): Upgraded to Buy at ThinkEquity; target raised to $26 (new Street high)
Tweet Send to a Friend
From Notable Calls
ThinkEquity is upgrading Human Genome Sciences (NASDAQ: HGSI) to Buy from Accumulate and raising their rating to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
ThinkEquity is upgrading Human Genome Sciences (NASDAQ: HGSI) to Buy from Accumulate and raising their rating to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
